1,653
Views
2
CrossRef citations to date
0
Altmetric
Back Matter

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions

ORCID Icon, , , , , , , , , , & show all
Article: 1741267 | Received 28 Sep 2019, Accepted 09 Jan 2020, Published online: 25 Mar 2020

References

  • Ascierto ML, Makohon-Moore A, Lipson EJ, Taube JM, McMiller TL, Berger AE, Fan J, Kaunitz GJ, Cottrell TR, Kohutek ZA, et al. Transcriptional mechanisms of resistance to anti-PD-1 therapy. Clin Cancer Res. 2017;23(12):3168–8. doi:10.1158/1078-0432.CCR-17-0270.
  • Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35–44. doi:10.1016/j.cell.2016.02.065.
  • Lauss M, Donia M, Harbst K, Andersen R, Mitra S, Rosengren F, Salim M, Vallon-Christersson J, Törngren T, Kvist A, et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat Commun. 2017;8(1):1738. doi:10.1038/s41467-017-01460-0.
  • Misra BB, Langefeld C, Olivier M, Cox LA. Integrated omics: tools, advances and future approaches. J. Mol. Endocrinol. 2019;62(1):R21.
  • Pinu FR, Beale DJ, Paten AM, Kouremenos K, Swarup S, Schirra HJ, Wishart D. Systems biology and multi-omics integration: viewpoints from the metabolomics research community. Metabolites. 2019;9(4):76. doi:10.3390/metabo9040076.
  • Lun ATL, Richard AC, Marioni JC. Testing for differential abundance in mass cytometry data. Nat Methods. 2017;14(7):707–709. doi:10.1038/nmeth.4295.
  • Zuleta IA, Aranda-Diaz A, Li H, El-Samad H. Dynamic characterization of growth and gene expression using high-throughput automated flow cytometry. Nat Methods. 2014;11(4):443–448. doi:10.1038/nmeth.2879.
  • Angelo M, Bendall SC, Finck R, Hale MB, Hitzman C, Borowsky AD, Levenson RM, Lowe JB, Liu SD, Zhao S, et al. Multiplexed ion beam imaging of human breast tumors. Nat Med. 2014;20(4):436–442. doi:10.1038/nm.3488.
  • Schapiro D, Jackson HW, Raghuraman S, Fischer JR, Zanotelli VRT, Schulz D, Giesen C, Catena R, Varga Z, Bodenmiller B, et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017;14(9):873–876. doi:10.1038/nmeth.4391.
  • Johnston ST, Shah ET, Chopin LK, Sean McElwain DL, Simpson MJ. Estimating cell diffusivity and cell proliferation rate by interpreting IncuCyte ZOOM assay data using the Fisher-Kolmogorov model. BMC Syst Biol. 2015;9:38. doi:10.1186/s12918-015-0182-y.
  • Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N, et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2010;16(9):2646–2655. doi:10.1158/1078-0432.CCR-10-0041.
  • Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26(4):332–342. doi:10.1097/00002371-200307000-00005.
  • Ortenberg R, Sapir Y, Raz L, Hershkovitz L, Ben Arav A, Sapoznik S, Barshack I, Avivi C, Berkun Y, Besser MJ, et al. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions. Mol Cancer Ther. 2012;11(6):1300–1310. doi:10.1158/1535-7163.MCT-11-0526.
  • Galore-Haskel G, Baruch EN, Berg AL, Barshack I, Zilinsky I, Avivi C, Besser MJ, Schachter J, Markel G. Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma. Oncotarget. 2017;8(59):99580–99586. doi:10.18632/oncotarget.v8i59.
  • Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. 2001;81(10):1331–1338. doi:10.1038/labinvest.3780347.
  • La Spada A, Baronchelli S, Ottoboni L, Ruffini F, Martino G, Convertino N, Ntai A, Steiner T, Biunno I, De Blasio A, et al. Cell line macroarray: an alternative high-throughput platform to analyze hiPSC lines. J Histochem Cytochem: Off J Histochem Soc. 2016;64(12):739–751. doi:10.1369/0022155416673969.
  • Markel G, Ortenberg R, Seidman R, Sapoznik S, Koren-Morag N, Besser MJ, Bar J, Shapira R, Kubi A, Nardini G, et al. Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol Immunother: CII. 2010;59(2):215–230. doi:10.1007/s00262-009-0740-5.
  • Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–682. doi:10.1038/nmeth.2019.
  • Browne SK, Roesser JR, Zhu SZ, Ginder GD. Differential IFN-gamma stimulation of HLA-A gene expression through CRM-1-dependent nuclear RNA export. J Immunol. 2006;177(12):8612–8619. doi:10.4049/jimmunol.177.12.8612.
  • Dai C, Krantz SB. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood. 1999;93(10):3309–3316. doi:10.1182/blood.V93.10.3309.410k04_3309_3316.
  • Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods. 2001;253(1–2):177–187. doi:10.1016/S0022-1759(01)00359-3.
  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37–43. doi:10.1038/376037a0.
  • Fortis SP, Mahaira LG, Anastasopoulou EA, Voutsas IF, Perez SA, Baxevanis CN. Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model. Cancer Immunol Immunother: CII. 2017;66(12):1631–1642. doi:10.1007/s00262-017-2056-1.
  • Gide TN, Allanson BM, Menzies AM, Ferguson PM, Madore J, Saw RPM, Thompson JF, Long GV, Wilmott JS, Scolyer RA, et al. Inter- and intrapatient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment. Histopathology. 2019;74(6):817–828. doi:10.1111/his.2019.74.issue-6.
  • Spranger S, Spaapen RM, Zha Y, Williams J, Meng Y, Ha TT, Gajewski TF. Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells. Sci Transl Med. 2013;5(200):200ra116. doi:10.1126/scitranslmed.3006504.
  • Melnik BC. MiR-21: an environmental driver of malignant melanoma? J Transl Med. 2015;13(1):202. doi:10.1186/s12967-015-0570-5.
  • Reinsbach S, Nazarov PV, Philippidou D, Schmitt M, Wienecke-Baldacchino A, Muller A, Vallar L, Behrmann I, Kreis S. Dynamic regulation of microRNA expression following interferon-gamma-induced gene transcription. RNA Biol. 2012;9(7):978–989. doi:10.4161/rna.20494.
  • Smith TRF, Kumar V. Revival of CD8+ Treg–mediated suppression. Trends Immunol. 2008;29(7):337–342. doi:10.1016/j.it.2008.04.002.
  • Zhang S, Wu M, Wang F. Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy. Cell Mol Immunol. 2018;15(9):805–807. doi:10.1038/cmi.2018.170.
  • Bolognesi MM, Manzoni M, Scalia CR, Zannella S, Bosisio FM, Faretta M, Cattoretti G. Multiplex staining by sequential immunostaining and antibody removal on routine tissue sections. J Histochem Cytochem: Off J Histochem Soc. 2017;65(8):431–444. doi:10.1369/0022155417719419.
  • Sorrelle N, Ganguly D, Dominguez ATA, Zhang, Y., Huang, H., Dahal, L.N., Burton, N., Ziemys, A., Brekken, R.A. Improved multiplex immunohistochemistry for immune microenvironment evaluation of mouse formalin-fixed, paraffin-embedded tissues. J Immunol. 2018;202:ji1800878.